Genomewide Association Study of Statin-Induced Myopathy in Patients Recruited Using the UK Clinical Practice Research Datalink.

Collapse authors list.
Carr, Daniel F ORCID: 0000-0001-8028-4282, Francis, Ben ORCID: 0000-0002-2130-5976, Jorgensen, Andrea L, Zhang, Eunice, Chinoy, Hector ORCID: 0000-0001-6492-1288, Heckbert, Susan R, Bis, Joshua C, Brody, Jennifer A, Floyd, James S, Psaty, Bruce M et al (show 6 more authors) , Molokhia, Mariam, Lapeyre-Mestre, Maryse, Conforti, Anita, Alfirevic, Ana ORCID: 0000-0002-2801-9817, van Staa, Tjeerd and Pirmohamed, Munir ORCID: 0000-0002-7534-7266 (2019) Genomewide Association Study of Statin-Induced Myopathy in Patients Recruited Using the UK Clinical Practice Research Datalink. Clinical pharmacology and therapeutics.

Text Author_accepted_manuscript.pdf - Author Accepted Manuscript Download (585kB) | Preview

Abstract

Statins can be associated with myopathy. We have undertaken a genomewide association study (GWAS) to discover and validate genetic risk factors for statin-induced myopathy in a "real-world" setting. One hundred thirty-five patients with statin myopathy recruited via the UK Clinical Practice Research Datalink were genotyped using the Illumina OmniExpress Exome version 1.0 Bead Chip and compared with the Wellcome Trust Case-Control Consortium (n = 2,501). Nominally statistically significant single nucleotide polymorphism (SNP) signals in the GWAS (P < 5 × 10-5 ) were further evaluated in several independent cohorts (comprising 332 cases and 449 drug-tolerant controls). Only one (rs4149056/c.521C>T in the SLCO1B1 gene) SNP was genomewide significant in the severe myopathy (creatine kinase > 10 × upper limit of normal or rhabdomyolysis) group (P = 2.55 × 10-9 ; odds ratio 5.15; 95% confidence interval 3.13-8.45). The association with SLCO1B1 was present for several statins and replicated in the independent validation cohorts. The data highlight the role of SLCO1B1 c.521C>T SNP as a replicable genetic risk factor for statin myopathy. No other novel genetic risk factors with a similar effect size were identified.

Item Type:	Article
Depositing User:	Symplectic Admin
Date Deposited:	29 May 2019 15:12
Last Modified:	19 Jan 2023 00:42
DOI:	10.1002/cpt.1557
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3043537

Available Versions of this Item

• Genomewide Association Study of Statin-Induced Myopathy in Patients Recruited Using the UK Clinical Practice Research Datalink. (deposited 29 May 2019 15:12) [Currently Displayed]
  • Genomewide Association Study of Statin‐Induced Myopathy in Patients Recruited Using the UK Clinical Practice Research Datalink. (deposited 31 Oct 2019 11:39)